1. Home
  2. GDRX vs NVCR Comparison

GDRX vs NVCR Comparison

Compare GDRX & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoodRx Holdings Inc.

GDRX

GoodRx Holdings Inc.

N/A

Current Price

$2.93

Market Cap

1.2B

Sector

Technology

ML Signal

N/A

Logo NovoCure Limited

NVCR

NovoCure Limited

N/A

Current Price

$10.74

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GDRX
NVCR
Founded
2011
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.4B
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
GDRX
NVCR
Price
$2.93
$10.74
Analyst Decision
Hold
Buy
Analyst Count
14
7
Target Price
$3.95
★ $26.14
AVG Volume (30 Days)
1.1M
★ 1.6M
Earning Date
12-01-2026
10-29-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 125.00
21.79
EPS
★ 0.03
N/A
Revenue
★ $796,853,000.00
$655,353,000.00
Revenue This Year
$0.20
$12.95
Revenue Next Year
$4.73
$9.33
P/E Ratio
$100.50
★ N/A
Revenue Growth
0.57
★ 8.28
52 Week Low
$1.77
$9.82
52 Week High
$3.89
$21.45

Technical Indicators

Market Signals
Indicator
GDRX
NVCR
Relative Strength Index (RSI) 31.40 27.46
Support Level $2.83 $10.14
Resistance Level $3.12 $18.43
Average True Range (ATR) 0.19 0.69
MACD -0.07 -0.16
Stochastic Oscillator 0.57 3.04

Price Performance

Historical Comparison
GDRX
NVCR

About GDRX GoodRx Holdings Inc.

GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: